India  

Nepal gives emergency use approval to Bharat Biotech's Covaxin

IndiaTimes Saturday, 20 March 2021
Nepal's national drug regulatory authority on Saturday granted emergency use approval to Bharat Biotech's Covaxin, becoming the third country to approve India's indigenously developed Covid-19 vaccine.
0
shares
ShareTweetSavePostSend
 

You Might Like


Related videos from verified sources

Pfizer To File for Full FDA Approval of Its COVID-19 Vaccine at the End of May [Video]

Pfizer To File for Full FDA Approval of Its COVID-19 Vaccine at the End of May

Pfizer To File for Full FDA Approval of Its COVID-19 Vaccine at the End of May. The announcement was made on May 4. Based on what we’ve seen, we believe that a durable demand for our Covid-19..

Credit: Wibbitz Top Stories     Duration: 00:53Published
India receives first lot of Sputnik V vaccine [Video]

India receives first lot of Sputnik V vaccine

India on May 01 got the first lot of Russia's Sputnik V vaccine. The shipment arrived at the Hyderabad airport where Indian authorities received the first batch of 1.5 lakh doses of the Russia-made..

Credit: ANI     Duration: 02:00Published
Zydus' Virafin gets emergency use approval for treating moderate COVID-19 cases [Video]

Zydus' Virafin gets emergency use approval for treating moderate COVID-19 cases

The Drugs Controller General of India (DGCI) has approved emergency use for Zydus Cadila's Pegylated Interferon alpha-2b, 'Virafin' for treating moderate COVID-19 infection in adults. A release by..

Credit: ANI     Duration: 02:01Published

Related news from verified sources

Covaxin demonstrates 81% efficacy, says Bharat Biotech on Phase 3 results

Covaxin is one of two Covid vaccines that was granted emergency use approval in the country in early January.
DNA

Covaxin gets emergency approval in Nepal

India’s first indigenous Covid-19 vaccine Covaxin, developed by Bharat Biotech and Indian Council of Medical Research-National Institute of Virology, Pune,...
IndiaTimes